RBM44

Across TCGA pan-cancer cohorts, RBM44 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RBM44 data layer compared with 4 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RBM44 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RBM44 expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.

BLCA, LUSC, and KIRC are the cancer types where RBM44 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	III,IV	0.766	0.564	.003	72	view →
LUSC	DFS	Median	II,III,IV	0.496	0.710	<.001	60	view →
KIRC	DFS	Tertile	II,III,IV	0.366	0.666	<.001	49	view →
LGG	DFS	Median	All	0.666	0.805	<.001	47	view →
UVM	OS	Median	III,IV	0.304	1.000	.008	34	view →
THCA	DFS	Median	II,III,IV	0.873	0.964	.007	22	view →
CESC	DFS	Median	III,IV	0.490	0.760	.015	20	view →
OV	DFS	Quartile	All	0.508	0.629	.005	14	view →
PAAD	DFS	Quartile	II,III,IV	0.589	0.341	.017	9	view →
SKCM	OS	Tertile	IV	0.823	0.263	.020	9	view →
KICH	DFS	Tertile	III,IV	0.351	1.000	.013	9	view →
BRCA	OS	Tertile	III,IV	0.946	0.832	.011	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RBM44–BLCA (OS)

Open the BLCA breakdown →